Brainstorm Cell Therapeutics Inc. financial data

Symbol
BCLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1325 Avenue Of Americas, 28 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
GOLDEN HAND RESOURCES INC (to 11/22/2004), WIZBANG TECHNOLOGIES INC (to 8/8/2003)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 29.7 % -27.7%
Debt-to-equity -215 % +51.4%
Return On Equity 309 % -64.1%
Return On Assets -269 % -6.88%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 79.7M shares +77.1%
Common Stock, Shares, Outstanding 79.6M shares +94.6%
Entity Public Float 78.9M USD -34%
Common Stock, Value, Issued 14K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 71.2M shares +79.4%
Weighted Average Number of Shares Outstanding, Diluted 71.2M shares +79.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.91M USD -42.1%
General and Administrative Expense 9.38M USD -9.87%
Operating Income (Loss) -16.3M USD +27.1%
Net Income (Loss) Attributable to Parent -12.7M USD +42.8%
Earnings Per Share, Basic -0.22 USD/shares +62.7%
Earnings Per Share, Diluted -0.22 USD/shares +62.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.47M USD +535%
Assets, Current 3.82M USD +215%
Property, Plant and Equipment, Net 558K USD -30.2%
Operating Lease, Right-of-Use Asset 1.11M USD -70.1%
Other Assets, Noncurrent 1.87M USD -58.8%
Assets 5.68M USD -1.11%
Accounts Payable, Current 5.34M USD +2.89%
Employee-related Liabilities, Current 1.07M USD
Accrued Liabilities, Current 718K USD +698%
Liabilities, Current 7.69M USD 0%
Operating Lease, Liability, Noncurrent 396K USD -79.6%
Liabilities 9.21M USD -4.35%
Retained Earnings (Accumulated Deficit) -221M USD -6.12%
Stockholders' Equity Attributable to Parent -3.53M USD +9.15%
Liabilities and Equity 5.68M USD -1.11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.4M USD +28.7%
Net Cash Provided by (Used in) Financing Activities 17.4M USD -17.5%
Net Cash Provided by (Used in) Investing Activities 2.19M USD +120%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 79.6M shares +94.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.65M USD +568%
Deferred Tax Assets, Valuation Allowance 50.8M USD +19%
Deferred Tax Assets, Gross 50.8M USD +19%
Operating Lease, Liability 962K USD -70.8%
Depreciation 259K USD -5.47%
Payments to Acquire Property, Plant, and Equipment 18K USD +1700%
Lessee, Operating Lease, Liability, to be Paid 1.03M USD -70.9%
Property, Plant and Equipment, Gross 3.45M USD +0.53%
Operating Lease, Liability, Current 566K USD -58.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 182K USD -86.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 556K USD -20%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +29.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71K USD -72.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 189K USD -86%
Lessee, Operating Lease, Liability, to be Paid, Year Four 179K USD -7.25%
Operating Lease, Payments 166K USD -57%